Table 1.
Demographics and Other Patient Characteristics Summary
| Characteristic | All Patients (n = 110) |
|---|---|
| Age, mean (SD) | 50 (11.7) |
| Sex, n (%) | |
| Male | 80 (72.7) |
| Female | 30 (27.3) |
| Race, n (%) | |
| African American | 64 (58.2) |
| White | 38 (34.5) |
| Hispanic | 6 (5.5) |
| Asian | 2 (1.8) |
| Years since HIV diagnosis, median (IQR) | 12.0 (11.0) |
| Years on ART, median (IQR) | 8.0 (8.0) |
| Preswitch CD4 count (cell/mm3), median (IQR) | 627.5 (381.0) |
| Preswitch BMI category, n (%) | |
| Underweight | 4 (3.6) |
| Normal weight | 34 (30.9) |
| Overweight | 31 (28.2) |
| Obese | 41 (37.3) |
| Other ART agent, n (%) | |
| Integrase inhibitor | 54 (49.1) |
| Protease inhibitor | 18 (16.4) |
| Nonnucleoside reverse-transcriptase inhibitor | 32 (29.1) |
| Other | 6 (5.4) |
| Concomitant medication cause weight gain, n (%) | 34 (30.9) |
| Concomitant medication cause weight loss, n (%) | 29 (26.4) |
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; HIV, human immunodeficiency virus; IQR, interquartile range; SD, standard deviation.